Predicting Long-term Outcomes After Cardiac Arrest by Using Serum NGAL

Predicting Long-term Outcomes After Cardiac Arrest by Using Serum NGAL: A Prospective, Observational Study

This study was performed to determine the prognosis of patients after cardiac arrest using serum markers called NGAL. The initial NGAL values of patients with post-cardiac arrest syndrome are checked by blood tests, and the long-term neurological prognosis and survival rate are collected after 6 months.

Serum NGAL is currently being used as a test to determine the likelihood of developing renal failure. However, in a previous study, serum NGAL correlated with neurological prognosis in post cardiac arrest syndrome patients. This prospective study attempts to see the role of serum NGAL as a prognostic factor by including a sufficient number of patients.

Inclusion Criteria:

• Adult patients who underwent targeted temperature management after out-of-hospital cardiac arrest.

Exclusion Criteria:

• Patients who did not survived 3 days after cardiac arrest.
• Pre-existing end-stage renal disease or dependence on renal replacement therapy